These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9736927)

  • 21. Genome-scale metabolic models as platforms for identification of novel genes as antimicrobial drug targets.
    Mienda BS; Salihu R; Adamu A; Idris S
    Future Microbiol; 2018 Mar; 13():455-467. PubMed ID: 29469596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fishing for new antimicrobials.
    Mukhopadhyay A; Peterson RT
    Curr Opin Chem Biol; 2006 Aug; 10(4):327-33. PubMed ID: 16822704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial genome sequencing and drug discovery.
    Allsop AE
    Curr Opin Biotechnol; 1998 Dec; 9(6):637-42. PubMed ID: 9889137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated genomics and chemical biology herald an era of sophisticated antibacterial discovery, from defining essential genes to target elucidation.
    Warrier T; Romano KP; Clatworthy AE; Hung DT
    Cell Chem Biol; 2022 May; 29(5):716-729. PubMed ID: 35523184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-evaluating the approach to drug target discovery in multidrug-resistant Gram-negative bacilli.
    Umland TC; Schultz LW; Russo TA
    Future Microbiol; 2014; 9(10):1113-6. PubMed ID: 25405880
    [No Abstract]   [Full Text] [Related]  

  • 26. Microscale Adaptation of In Vitro Transcription/Translation for High-Throughput Screening of Natural Product Extract Libraries.
    Lowell AN; Santoro N; Swaney SM; McQuade TJ; Schultz PJ; Larsen MJ; Sherman DH
    Chem Biol Drug Des; 2015 Dec; 86(6):1331-8. PubMed ID: 26147927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovering new antimicrobial agents.
    Moellering RC
    Int J Antimicrob Agents; 2011 Jan; 37(1):2-9. PubMed ID: 21075608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging mechanisms of antimicrobial resistance in bacteria and fungi: advances in the era of genomics.
    Sekyere JO; Asante J
    Future Microbiol; 2018 Feb; 13():241-262. PubMed ID: 29319341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics.
    Obrecht D; Robinson JA; Bernardini F; Bisang C; DeMarco SJ; Moehle K; Gombert FO
    Curr Med Chem; 2009; 16(1):42-65. PubMed ID: 19149562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-infectives: can cellular screening deliver?
    Keller TH; Shi PY; Wang QY
    Curr Opin Chem Biol; 2011 Aug; 15(4):529-33. PubMed ID: 21723774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New targets and screening approaches in antimicrobial drug discovery.
    Brown ED; Wright GD
    Chem Rev; 2005 Feb; 105(2):759-74. PubMed ID: 15700964
    [No Abstract]   [Full Text] [Related]  

  • 34. In Ssarch of new anti-bacterial target genes: a comparative/structural genomics approach.
    Claverie JM; Monchois V; Audic S; Poirot O; Abergel C
    Comb Chem High Throughput Screen; 2002 Nov; 5(7):511-22. PubMed ID: 12470264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico analysis of Burkholderia pseudomallei genome sequence for potential drug targets.
    Chong CE; Lim BS; Nathan S; Mohamed R
    In Silico Biol; 2006; 6(4):341-6. PubMed ID: 16922696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance surveillance in the genomic age.
    McArthur AG; Tsang KK
    Ann N Y Acad Sci; 2017 Jan; 1388(1):78-91. PubMed ID: 27875856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Target-based antimicrobial drug discovery.
    Alksne LE; Dunman PM
    Methods Mol Biol; 2008; 431():271-83. PubMed ID: 18287763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innovative approaches to novel antibacterial drug discovery.
    Trias J; Gordon EM
    Curr Opin Biotechnol; 1997 Dec; 8(6):757-62. PubMed ID: 9425668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.